4//SEC Filing
Wegman Mark N 4
Accession 0001062993-19-002432
CIK 0000875622other
Filed
May 27, 8:00 PM ET
Accepted
May 28, 7:10 PM ET
Size
4.8 KB
Accession
0001062993-19-002432
Insider Transaction Report
Form 4
Wegman Mark N
Director
Transactions
- Sale
Common Stock, $0.001 par value
2019-05-24$61.09/sh−7,800$476,502→ 65,272 total
Footnotes (1)
- [F1]The selling price of $61.09 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $60.83 to $61.80. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Issuer
BIOSPECIFICS TECHNOLOGIES CORP
CIK 0000875622
Entity typeother
Related Parties
1- filerCIK 0001405235
Filing Metadata
- Form type
- 4
- Filed
- May 27, 8:00 PM ET
- Accepted
- May 28, 7:10 PM ET
- Size
- 4.8 KB